Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 141

1.

Comment on: Lack of association between obesity and aggressiveness of differentiated thyroid cancer.

Campennì A, Trimarchi F, Baldari S.

J Endocrinol Invest. 2018 Oct 20. doi: 10.1007/s40618-018-0970-5. [Epub ahead of print] No abstract available.

PMID:
30343357
2.

Stem cells under the influence of alcohol: effects of ethanol consumption on stem/progenitor cells.

Di Rocco G, Baldari S, Pani G, Toietta G.

Cell Mol Life Sci. 2018 Oct 10. doi: 10.1007/s00018-018-2931-8. [Epub ahead of print] Review.

PMID:
30306211
3.

Protein disulfide isomerase as a prosurvival factor in cell therapy for muscular and vascular diseases.

Di Rocco G, Baldari S, Gentile A, Capogrossi M, Toietta G.

Stem Cell Res Ther. 2018 Sep 26;9(1):250. doi: 10.1186/s13287-018-0986-y.

4.

Narrative medicine in metastatic prostate cancer reveals ways to improve patient awareness & quality of care.

De Vincentis G, Monari F, Baldari S, Salgarello M, Frantellizzi V, Salvi E, Reale L, Napolitano S, Conti G, Cortesi E.

Future Oncol. 2018 Nov;14(27):2821-2832. doi: 10.2217/fon-2018-0318. Epub 2018 Jun 15.

5.

A Monte Carlo model for the internal dosimetry of choroid plexuses in nuclear medicine procedures.

Amato E, Cicone F, Auditore L, Baldari S, Prior JO, Gnesin S.

Phys Med. 2018 May;49:52-57. doi: 10.1016/j.ejmp.2018.05.005. Epub 2018 May 10.

PMID:
29866344
6.

Italian Multicenter Study on Accuracy of 18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma.

Cistaro A, Cassalia L, Ferrara C, Quartuccio N, Evangelista L, Bianchi M, Fagioli F, Bisi G, Baldari S, Zanella A, Pillon M, Zucchetta P, Burei M, Sala A, Guerra L, Guglielmo P, Burnelli R, Panareo S, Scalorbi F, Rambaldi I, Piccardo A, Garaventa A, Familiari D, Fornito MC, Lopci E, Mascarin M, Altini C, Ferrari C, Perillo T, Santoro N, Borsatti E, Rubini G.

Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):e267-e273. doi: 10.1016/j.clml.2018.04.002. Epub 2018 Apr 14.

PMID:
29739722
7.

Undetectable or low (<1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients.

Campennì A, Giovanella L, Pignata SA, Vento A, Alibrandi A, Sturiale L, Laudicella R, Comis AD, Filice R, Giuffrida G, Stipo ME, Giovinazzo S, Trimarchi F, Ruggeri RM, Baldari S.

Oncotarget. 2018 Apr 3;9(25):17491-17500. doi: 10.18632/oncotarget.24766. eCollection 2018 Apr 3.

8.

Combined BRAFV600E analysis and 99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation.

Campennì A, Ruggeri RM, Siracusa M, Pignata SA, Di Mauro F, Vento A, Trimarchi F, Baldari S.

J Endocrinol Invest. 2018 Nov;41(11):1283-1288. doi: 10.1007/s40618-018-0864-6. Epub 2018 Mar 16.

PMID:
29549631
9.

Radiation protection from external exposure to radionuclides: A Monte Carlo data handbook.

Amato E, Italiano A, Auditore L, Baldari S.

Phys Med. 2018 Feb;46:160-167. doi: 10.1016/j.ejmp.2018.02.003. Epub 2018 Feb 8.

PMID:
29519404
10.

Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies.

Baldari S, Di Rocco G, Piccoli M, Pozzobon M, Muraca M, Toietta G.

Int J Mol Sci. 2017 Oct 2;18(10). pii: E2087. doi: 10.3390/ijms18102087. Review.

11.

Multicentre clinical evaluation of the new highly sensitive Elecsys® thyroglobulin II assay in patients with differentiated thyroid carcinoma.

Trimboli P, Imperiali M, Piccardo A, CampennÌ A, Giordani I, Ruggeri RM, Baldari S, Orlandi F, Giovanella L.

Clin Endocrinol (Oxf). 2018 Feb;88(2):295-302. doi: 10.1111/cen.13487. Epub 2017 Oct 18.

PMID:
28960391
12.

11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients.

Incerti E, Gangemi V, Mapelli P, Deantoni CL, Giovacchini G, Fallanca F, Fodor A, Ciarmiello A, Baldari S, Gianolli L, Di Muzio N, Picchio M.

Curr Radiopharm. 2017 Nov 10;10(3):195-202. doi: 10.2174/1874471010666170919162517.

PMID:
28933270
13.

p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions.

Garufi A, Pistritto G, Baldari S, Toietta G, Cirone M, D'Orazi G.

J Exp Clin Cancer Res. 2017 Sep 11;36(1):126. doi: 10.1186/s13046-017-0596-z.

14.

Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: a new quantitative method for improving diagnostic accuracy.

Campennì A, Siracusa M, Ruggeri RM, Laudicella R, Pignata SA, Baldari S, Giovanella L.

Sci Rep. 2017 Jul 21;7(1):6147. doi: 10.1038/s41598-017-06603-3.

15.

A didactic experiment showing the Compton scattering by means of a clinical gamma camera.

Amato E, Auditore L, Campennì A, Minutoli F, Cucinotta M, Sindoni A, Baldari S.

Phys Med. 2017 Jun;38:119-121. doi: 10.1016/j.ejmp.2017.05.061. Epub 2017 Jun 2.

PMID:
28610692
16.

Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer.

Picciotto M, Franchina T, Russo A, Ricciardi GRR, Provazza G, Sava S, Baldari S, Caffo O, Adamo V.

Expert Opin Pharmacother. 2017 Jun;18(9):899-908. doi: 10.1080/14656566.2017.1323875. Epub 2017 May 8. Review.

PMID:
28449621
17.

Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panel.

Baldari S, Boni G, Bortolus R, Caffo O, Conti G, De Vincentis G, Monari F, Procopio G, Santini D, Seregni E, Valdagni R.

Crit Rev Oncol Hematol. 2017 May;113:43-51. doi: 10.1016/j.critrevonc.2017.03.001. Epub 2017 Mar 6. Review.

PMID:
28427521
18.

Emerging treatment modalities for advanced pancreatic neuroendocrine tumors.

Sindoni A, Famà F, Gioffre-Florio M, Baldari S.

Hormones (Athens). 2016 Oct;15(4):563-564. doi: 10.14310/horm.2002.1702. No abstract available.

19.

Theoretical estimation of 64Cu production with neutrons emitted during 18F production with a 30MeV medical cyclotron.

Auditore L, Amato E, Baldari S.

Appl Radiat Isot. 2017 Apr;122:229-234. doi: 10.1016/j.apradiso.2017.02.002. Epub 2017 Feb 3.

PMID:
28209500
20.

Towards Therapeutic Delivery of Extracellular Vesicles: Strategies for In Vivo Tracking and Biodistribution Analysis.

Di Rocco G, Baldari S, Toietta G.

Stem Cells Int. 2016;2016:5029619. Epub 2016 Nov 23. Review.

Supplemental Content

Loading ...
Support Center